Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

NCT07224490 is registered in ClinicalTrials.gov with Stephanie B. Seminara, MD as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Lead sponsor
Stephanie B. Seminara, MD
Phase
Phase 1
Overall status
Recruiting
Start date
March 10, 2026
Completion date
May 31, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, neurodegeneration, reproductive disorder, sars-cov 2